These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 38235126)
1. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion. Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q Front Immunol; 2023; 14():1290839. PubMed ID: 38235126 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of endoplasmic reticulum stress related signature in head and neck squamous carcinoma. Miao Y; Chen Q; Liu X; Bu J; Zhang Z; Liu T; Yue Z; Huang L; Sun S; Li H; Yang A; Yang Z; Chen C Sci Rep; 2024 Jul; 14(1):16972. PubMed ID: 39043683 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study. Wu XQ; Tian X; Xu FJ; Wang Y; Xu WH; Su JQ; Qu YY; Zhao JY; Zhang HL; Ye DW Bioengineered; 2022 May; 13(5):14000-14012. PubMed ID: 35726370 [TBL] [Abstract][Full Text] [Related]
4. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway. Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845 [TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma. Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X Gene; 2022 Jun; 827():146461. PubMed ID: 35358652 [TBL] [Abstract][Full Text] [Related]
6. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
7. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer]. Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766 [No Abstract] [Full Text] [Related]
8. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis. Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348 [TBL] [Abstract][Full Text] [Related]
9. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation. Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ Front Genet; 2023; 14():1041042. PubMed ID: 36936420 [No Abstract] [Full Text] [Related]
10. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis. Huang J; Liang B; Wang T Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372 [TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma. Hu R; Lu M; She L Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444 [TBL] [Abstract][Full Text] [Related]
12. LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function. Tian X; Hu D; Wang N; Zhang L; Wang X Front Genet; 2024; 15():1337525. PubMed ID: 38655053 [TBL] [Abstract][Full Text] [Related]
13. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571 [TBL] [Abstract][Full Text] [Related]
14. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma. Chen Y Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491 [TBL] [Abstract][Full Text] [Related]
15. FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma. Wu Q; Shao T; Huang G; Zheng Z; Jiang Y; Zeng W; Lv X Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291667 [No Abstract] [Full Text] [Related]
16. TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis. Chen L; Lin W; Zhang H; Geng S; Le Z; Wan F; Huang Q; Chen H; Liu X; Lu JJ; Kong L Cell Death Dis; 2024 Mar; 15(3):178. PubMed ID: 38429254 [TBL] [Abstract][Full Text] [Related]
17. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes. Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534 [TBL] [Abstract][Full Text] [Related]
18. TRIB3 reduces CD8 Shang S; Yang YW; Chen F; Yu L; Shen SH; Li K; Cui B; Lv XX; Zhang C; Yang C; Liu J; Yu JJ; Zhang XW; Li PP; Zhu ST; Zhang HZ; Hua F Sci Transl Med; 2022 Jan; 14(626):eabf0992. PubMed ID: 34985967 [TBL] [Abstract][Full Text] [Related]
19. Biomarker Potential of Ju Y; Zhu F; Fang B Int J Med Sci; 2024; 21(5):921-936. PubMed ID: 38617010 [TBL] [Abstract][Full Text] [Related]
20. ADAMTS12, a novel prognostic predictor, promotes cell proliferation, migration, and invasion in head and neck squamous cell carcinoma. Li M; Yuan Z; Tang Z Oral Dis; 2024 Mar; 30(2):235-246. PubMed ID: 36222542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]